Curanex Pharmaceuticals Inc Company Profile
NASDAQ: CURXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Curanex Pharmaceuticals at a glance
Curanex Pharmaceuticals Inc (NASDAQ: CURX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Jericho, NY. Curanex Pharmaceuticals is led by Mr. Jun Liu and employs about 6 people. The company's shares have traded publicly since 2025.
At a market capitalization of $7.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002025942, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Curanex Pharmaceuticals do?
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Curanex Pharmaceuticals Inc
- Ticker
- NASDAQ: CURX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Jun Liu
- Employees
- 6
- Headquarters
- 2 Jericho Plaza, Jericho, NY, United States
- Phone
- 718 673 6078
- Website
- curanexpharma.com
- IPO year
- 2025
- Market cap
- $7.48M
- SEC CIK
- 0002025942
- Latest annual report
- 10-K · Mar 30, 2026
Companies similar to Curanex Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SKYESkye Bioscience Inc. | 1.69 | +0.60% | $7.48M | vs CURX |
| INMInMed Pharmaceuticals Inc. | 1.36 | +2.24% | $7.47M | vs CURX |
| APREAprea Therapeutics Inc. | 0.6044 | +8.28% | $7.61M | vs CURX |
| CNSPCNS Pharmaceuticals Inc. | 5.23 | -2.24% | $7.64M | vs CURX |
| FBLGFibroBiologics Inc. | 1.13 | +1.80% | $7.86M | vs CURX |
| AZTRAzitra Inc | 0.1299 | -1.59% | $7.87M | vs CURX |
| ACXPAcurx Pharmaceuticals Inc. | 1.27 | +1.60% | $7.06M | vs CURX |
| LGVNLongeveron Inc. Class A | 2.48 | +4.68% | $7.91M | vs CURX |